Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000004

Principal Accounting Officer sold 2,272 shares at $34.39 ($78,134)

  • Principal Accounting Officer acquired 6,896 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Washburn Theodore James Jr. · Principal Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-01 Exercise or conversion : show line 1 in the form 10b5-1 +6,896 7,709 D
2025-02-05 Sale : show line 2 in the form 10b5-1 −2,272 $34.39 $78,134 5,437 D
Open-market sales · 2,272 sh · avg $34.39 · $78,134

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-01 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −6,896 0 D
Loading xslF345X05/wk-form4_1738789362.xml…